Brazil covid-19 testing vaccine Brazil

PDS Biotech and Farmacore partner to develop Covid-19 vaccine

Reading now: 620
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.US-based immunotherapy company PDS Biotechnology has partnered with Brazilian biotechnology firm Farmacore Biotechnology to jointly develop a Covid-19 vaccine.

The vaccine candidate, Versamune-CoV-2FC (PDS0204), is based on PDS Biotechnology’s immune-activating Versamune platform, integrating a recombinant fusion protein of SARS-CoV-2 developed by Farmacore to be recognised by the human immune system.

The vaccine is expected to rapidly trigger neutralising antibodies, killer T-cells and memory T-cells against the SARS-CoV-2 virus.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA